BioLucent
North America, Massachusetts, United States, Bedford
Description
Hologic, Inc. (NASDAQ: HOLX) has grown to become a leading developer, manufacturer and supplier of premium diagnostic products, medical
Investor Profile
BioLucent has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (100%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
